1. Home
  2. DRMAW

DRMAW

Dermata Therapeutics Inc. Warrant

Logo Dermata Therapeutics Inc. Warrant

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 03-12-2024 5:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Founded: N/A Country:
United States
United States
Employees: 8 City: SAN DIEGO
Market Cap: N/A IPO Year: 2021
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: